logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
ImatinibIC5030000.0 [1], 100000.0 [2]
BosutinibIC50150.0 [1], 200.0 [2], 10000.0 [3], 20000.0 [4]
6-(2,6-Dichlorophenyl)-8-methyl-2-((3-(methylthio)phenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-oneIC502500.0 [1], 3000.0 [2], 30000.0 [3]
N-[2-[2-[4-[4-[(2S)-2-Hydroxypropyl]piperazin-1-yl]-2-methoxyanilino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]-N-methylmethanesulfonamideIC5060.0 [1]
5-(1,3-Benzodioxol-5-yl)-N-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxo-1H-pyridine-3-carboxamideIC503600.0 [1], 6500.0 [2]

References
This online resource may be cited as follows
MLA
"Quest DatabaseNPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) Inhibitors (IC50, Ki)." AAT Bioquest, Inc.14 Dec2025https://www.aatbio.com/data-sets/npm-alk-nucleophosmin-alk-tyrosine-kinase-receptor-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025December 14). Quest DatabaseNPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor) Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/npm-alk-nucleophosmin-alk-tyrosine-kinase-receptor-inhibitors-ic50-ki.
BibTeXEndNoteRefMan